{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:16:26Z","timestamp":1768738586029,"version":"3.49.0"},"reference-count":102,"publisher":"Bentham Science Publishers Ltd.","issue":"35","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00100\/2013"],"award-info":[{"award-number":["UID\/QUI\/00100\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["IF\/00849\/2012"],"award-info":[{"award-number":["IF\/00849\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,12,13]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The search for new metal-efficient drugs has attracted considerable attention of the\nscientific community. Among them, ruthenium complexes have emerged as an excellent alternative\nof platinum complexes. This review presents a thorough and timely coverage of the synthesis,\nbiological activity and medicinal applications of ruthenium complexes bearing carbohydrate ligands,\nallowing a large community of readers, in particularly the community that works in organic,\ninorganic, bioorganometallic and medicinal chemistry, ready access to the most relevant examples.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190124124350","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T05:15:55Z","timestamp":1548393355000},"page":"6412-6437","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthesis, Biological Activity and Medicinal Applications of Ruthenium Complexes Containing Carbohydrate Ligands"],"prefix":"10.2174","volume":"26","author":[{"given":"Ana Cristina","family":"Fernandes","sequence":"first","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural, Instituto Superior T\u00e9cnico, Universidade de Lisboa, Av. Rovisco Pais, 1049- 001 Lisboa, Portugal"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1039\/b601840h","author":"Dyson P.J.","year":"2006","unstructured":"Dyson P.J.; Sava G.; Metal-based antitumour drugs in the post genomic era. Dalton Trans 2006(16),1929-1933","journal-title":"Dalton Trans"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1039\/B707077M","volume":"38","author":"Hartinger C.G.","year":"2009","unstructured":"Hartinger C.G.; Dyson P.J.; Bioorganometallic chemistry-from teaching paradigms to medicinal applications. Chem Soc Rev 2009,38,391-401","journal-title":"Chem Soc Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/jm100020w","volume":"54","author":"Gasser G.","year":"2011","unstructured":"Gasser G.; Ott I.; Metzler-Nolte. N. Organometallic anticancer compounds. J Med Chem 2011,54,3-25","journal-title":"J Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.ccr.2012.12.015","volume":"257","author":"Monney A.","year":"2013","unstructured":"Monney A.; Albrecht M.; Transition metal bioconjugates with an organometallic link between the metal and the biomolecular scaffold. Coord Chem Rev 2013,257,2420-2433","journal-title":"Coord Chem Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccr.2014.08.002","volume":"284","author":"Medici S.","year":"2015","unstructured":"Medici S.; Peana M.; Nurchi V.M.; Lachowicz J.I.; Crisponi G.; Zoroddu M.A.; Noble metals in medicine: latest advances. Coord Chem Rev 2015,284,329-350","journal-title":"Coord Chem Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/205698a0","volume":"205","author":"Rosenberg B.","year":"1965","unstructured":"Rosenberg B.; Vancamp L.; Krigas T.; Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965,205,698-699","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/222385a0","volume":"222","author":"Rosenberg B.","year":"1969","unstructured":"Rosenberg B.; VanCamp L.; Trosko J.E.; Mansour V.H.; Platinum compounds: a new class of potent antitumour agents. Nature 1969,222(5191),385-386","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2174\/092986706776872970","volume":"13","author":"Abu-Surrah A.S.","year":"2006","unstructured":"Abu-Surrah A.S.; Kettunen M.; Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin. Curr Med Chem 2006,13(11),1337-1357","journal-title":"Curr Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157489206775246458","volume":"1","author":"Kostova I.","year":"2006","unstructured":"Kostova I.; Platinum complexes as anticancer agents. Recent Patents Anticancer Drug Discov 2006,1,1-22","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"19157","DOI":"10.1039\/C6DT03665A","volume":"45","author":"Mitra K.","year":"2016","unstructured":"Mitra K.; Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation. Dalton Trans 2016,45(48),19157-19171","journal-title":"Dalton Trans"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0010-8545(02)00312-0","volume":"236","author":"Clarke M.","year":"2003","unstructured":"Clarke M.; Ruthenium metallopharmaceuticals. J Coord Chem Rev 2003,236,209-233","journal-title":"J Coord Chem Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1002\/ejic.200600723","author":"Ang W.H.","year":"2006","unstructured":"Ang W.H.; Dyson P.J.; Classical and non\u2010classical ruthenium\u2010based anticancer drugs: Towards targeted chemotherapy. Eur J Inorg Chem 2006,4003-4018","journal-title":"Eur J Inorg Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1039\/b617769g","author":"Bergamo A.","year":"2007","unstructured":"Bergamo A.; Sava G.; Ruthenium complexes can target determinants of tumour malignancy. Dalton Trans 2007(13),1267-1272","journal-title":"Dalton Trans"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1039\/b904071d","volume":"1","author":"Levina A.","year":"2009","unstructured":"Levina A.; Mitra A.; Lay P.A.; Recent developments in ruthenium anticancer drugs. Metallomics 2009,1(6),458-470","journal-title":"Metallomics"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1039\/c0dt01816c","volume":"40","author":"Bergamo A.","year":"2011","unstructured":"Bergamo A.; Sava G.; Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs. Dalton Trans 2011,40(31),7817-7823","journal-title":"Dalton Trans"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jinorgbio.2011.09.030","volume":"106","author":"Bergamo A.","year":"2012","unstructured":"Bergamo A.; Gaiddon C.; Schellens J.H.; Beijnen J.H.; Sava G.; Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates. J Inorg Biochem 2012,106(1),90-99","journal-title":"J Inorg Biochem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jorganchem.2013.09.016","volume":"751","author":"Nazarov A.A.","year":"2014","unstructured":"Nazarov A.A.; Hartinger C.G.; Dyson P.J.; Opening the lid on piano-stool complexes: an account of ruthenium(II)\u2013arene complexes with medicinal applications. J Organomet Chem 2014,751,251-260","journal-title":"J Organomet Chem"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/859730","author":"Motswainyana W. M.","year":"2015","unstructured":"Motswainyana W. M.; Ajibade P. A.; Anticancer activities\nof mononuclear ruthenium(II) coordination complexes. Adv\nChem Article ID 859730.2015","journal-title":"Adv\nChem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1039\/C7CS00195A","volume":"46","author":"Zeng L.","year":"2017","unstructured":"Zeng L.; Gupta P.; Chen Y.; Wang E.; Ji L.; Chao H.; Chen Z-S.; The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev 2017,46(19),5771-5804","journal-title":"Chem Soc Rev"},{"key":"ref=20","first-page":"231","volume":"11","author":"Clarke M.","year":"1980","unstructured":"Clarke M.; \n                        J. Oncological implications of the chemistry of ruthenium. Met Ions Biol Syst 1980,11,231-283","journal-title":"Met Ions Biol Syst"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1155\/MBD.1994.41","volume":"1","author":"Mestroni G.","year":"1994","unstructured":"Mestroni G.; Alessio E.; Sava G.; Pacor S.; Coluccia M.; Boccarelli A.; Water-soluble ruthenium(iii)-dimethyl sulfoxide complexes: chemical behaviour and pharmaceutical properties. Met Based Drugs 1994,1(1),41-63","journal-title":"Met Based Drugs"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1023\/A:1006521715400","volume":"16","author":"Sava G.","year":"1998","unstructured":"Sava G.; Capozzi I.; Clerici K.; Gagliardi G.; Alessio E.; Mestroni G.; Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex. Clin Exp Metastasis 1998,16(4),371-379","journal-title":"Clin Exp Metastasis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","volume":"10","author":"Rademaker-Lakhai J.M.","year":"2004","unstructured":"Rademaker-Lakhai J.M.; van den Bongard D.; Pluim D.; Beijnen J.H.; Schellens J.H.M.; A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res 2004,10(11),3717-3727","journal-title":"Clin Cancer Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1124\/jpet.104.066175","volume":"310","author":"Pacor S.","year":"2004","unstructured":"Pacor S.; Zorzet S.; Cocchietto M.; Bacac M.; Vadori M.; Turrin C.; Gava B.; Castellarin A.; Sava G.; Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment. J Pharmacol Exp Ther 2004,310(2),737-744","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10637-014-0179-1","volume":"33","author":"Leijen S.","year":"2015","unstructured":"Leijen S.; Burgers S.A.; Baas P.; Pluim D.; Tibben M.; van Werkhoven E.; Alessio E.; Sava G.; Beijnen J.H.; Schellens J.H.M.; Phase I\/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy. Invest New Drugs 2015,33(1),201-214","journal-title":"Invest New Drugs"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ejic.201600986","volume":"12","author":"Alessio E.","year":"2017","unstructured":"Alessio E.; Thirty years of the drug candidate NAMI\u2010A and the myths in the field of ruthenium anticancer compounds: a personal perspective. Eur J Inorg Chem 2017,12,1549-1560","journal-title":"Eur J Inorg Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/cbdv.200890195","volume":"5","author":"Hartinger C.G.","year":"2008","unstructured":"Hartinger C.G.; Jakupec M.A.; Zorbas-Seifried S.; Groessl M.; Egger A.; Berger W.; Zorbas H.; Dyson P.J.; Keppler B.K.; KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers 2008,5(10),2140-2155","journal-title":"Chem Biodivers"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/CAD.0b013e328322fbc5","volume":"20","author":"Lentz F.","year":"2009","unstructured":"Lentz F.; Drescher A.; Lindauer A.; Henke M.; Hilger R.A.; Hartinger C.G.; Scheulen M.E.; Dittrich C.; Keppler B.K.; Jaehde U.; Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study. Anticancer Drugs 2009,20(2),97-103","journal-title":"Anticancer Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","volume":"100","author":"Hartinger C.G.","year":"2006","unstructured":"Hartinger C.G.; Zorbas-Seifried S.; Jakupec M.A.; Kynast B.; Zorbas H.; Bernhard K.; Keppler B.K.; From bench to bedside \u2013 preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem 2006,100(5-6),891-904","journal-title":"J Inorg Biochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1166\/jbn.2014.1763","volume":"10","author":"Heffeter P.","year":"2014","unstructured":"Heffeter P.; Riabtseva A.; Senkiv Y.; Kowol C.R.; K\u00f6rner W.; Jungwith U.; Mitina N.; Keppler B.K.; Konstantinova T.; Yanchuk I.; Stoika R.; Zaichenko A.; Berger W.; Nanoformulation improves activity of the (pre) clinical anticancer ruthenium complex KP1019. J Biomed Nanotechnol 2014,10(5),877-884","journal-title":"J Biomed Nanotechnol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1039\/C3SC53243G","volume":"5","author":"Trondl R.","year":"2014","unstructured":"Trondl R.; Heffeter P.; Kowol C.R.; Jakupec M.A.; Bergerbd W.; Keppler B.K.; NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application. Chem Sci (Camb) 2014,5(8),2925-2932","journal-title":"Chem Sci (Camb)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jinorgbio.2016.02.037","volume":"160","author":"Bytzek A.K.","year":"2016","unstructured":"Bytzek A.K.; Koellensperger G.; Keppler B.K.G.; Hartinger C.; Biodistribution of the novel anticancer drug sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] KP-1339\/IT139 in nude BALB\/c mice and implications on its mode of action. J Inorg Biochem 2016,160,250-255","journal-title":"J Inorg Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/chem.200400719","volume":"11","author":"Storr T.","year":"2005","unstructured":"Storr T.; Obata M.; Fisher C.L.; Bayly S.R.; Green D.E.; Brudzi\u00c7ska, I.; Mikata, Y.; Patrick, B. O.; Adam, M. J.; Yano, S.; Orvig, C. Novel carbohydrate\u2010appended metal complexes for potential use in molecular imaging. Chemistry 2005,11(11),195-203","journal-title":"Chemistry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.2174\/092986708785908978","volume":"15","author":"Hartinger C.G.","year":"2008","unstructured":"Hartinger C.G.; Nazarov A.A.; Ashraf S.M.; Dyson P.J.; Keppler B.K.; Carbohydrate-metal complexes and their potential as anticancer agents. Curr Med Chem 2008,15(25),2574-2591","journal-title":"Curr Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/chem.200802013","volume":"15","author":"Gottschaldt M.","year":"2009","unstructured":"Gottschaldt M.; Schubert U.S.; Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications. Chemistry 2009,15(7),1548-1557","journal-title":"Chemistry"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/jm100020w","volume":"54","author":"Gasser G.","year":"2011","unstructured":"Gasser G.; Ott I.; Metzler-Nolte. Organometallic anticancer compounds. N J Med Chem 2011,54,3-25","journal-title":"N J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ejoc.201201457","author":"Morais G.R.","year":"2013","unstructured":"Morais G.R.; Falconer R.A.; Santos I.; Carbohydrate\u2010based molecules for molecular imaging in nuclear medicine. Eur J Org Chem 2013,1401-1414","journal-title":"Eur J Org Chem"},{"key":"ref=38","first-page":"36","volume":"1","author":"Pettenuzzo A.","year":"2015","unstructured":"Pettenuzzo A.; Pigot R.; Ronconi L.; Metal-based glycoconjugates and their potential in targeted anticancer chemotherapy. Metallodrugs 2015,1(1),36-61","journal-title":"Metallodrugs"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1021\/ic202029e","volume":"51","author":"Webb M.I.","year":"2012","unstructured":"Webb M.I.; Chard R.A.; Al-Jobory Y.M.; Jones M.R.; Wong E.W.Y.; Walsby C.J.; Pyridine analogues of the antimetastatic Ru(III) complex NAMI-A targeting non-covalent interactions with albumin. Inorg Chem 2012,51(2),954-966","journal-title":"Inorg Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1039\/b820368g","author":"Vaccaro M.","year":"2009","unstructured":"Vaccaro M.; Del Litto R.; Mangiapia G.; Carnerup A.M.; D\u2019Errico G.; Ruffo F.; Paduano L.; Lipid based nanovectors containing ruthenium complexes: a potential route in cancer therapy. Chem Commun (Camb) 2009(11),1404-1406","journal-title":"Chem Commun (Camb)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.biomaterials.2012.01.057","volume":"33","author":"Mangiapia G.","year":"2012","unstructured":"Mangiapia G.; D\u2019Errico G.; Simeone L.; Irace C.; Radulescu A.; Di Pascale A.; Colonna A.; Montesarchio D.; Paduano L.; Ruthenium-based complex nanocarriers for cancer therapy. Biomaterials 2012,33(14),3770-3782","journal-title":"Biomaterials"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/bc200565v","volume":"23","author":"Simeone L.","year":"2012","unstructured":"Simeone L.; Mangiapia G.; Vitiello G.; Irace C.; Colonna A.; Ortona O.; Montesarchio D.; Paduano L.; Cholesterol-based nucleolipid-ruthenium complex stabilized by lipid aggregates for antineoplastic therapy. Bioconjug Chem 2012,23,758-770","journal-title":"Bioconjug Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1039\/c1mb05143a","volume":"7","author":"Simeone L.","year":"2011","unstructured":"Simeone L.; Mangiapia G.; Irace C.; Di Pascale A.; Colonna A.; Ortona O.; De Napoli L.; Montesarchio D.; Paduano L.; Nucleolipid nanovectors as molecular carriers for potential applications in drug delivery. Mol Biosyst 2011,7(11),3075-3086","journal-title":"Mol Biosyst"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1039\/c1dt10084j","volume":"40","author":"Tan C.","year":"2011","unstructured":"Tan C.; Wu S.; Lai S.; Wang M.; Chen Y.; Zhou L.; Zhu Y.; Lian W.; Peng W.; Ji L.; Xu A.; Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-norharman complexes. Dalton Trans 2011,40(34),8611-8621","journal-title":"Dalton Trans"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1021\/bm400104b","volume":"14","author":"Mangiapia G.","year":"2013","unstructured":"Mangiapia G.; Vitiello G.; Irace C.; Santamaria R.; Colonna A.; Angelico R.; Radulescu A.; D\u2019Errico G.; Montesarchio D.; Paduano L.; Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity. Biomacromolecules 2013,14(8),2549-2560","journal-title":"Biomacromolecules"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1039\/C4TB01807A","volume":"3","author":"Vitiello G.","year":"2015","unstructured":"Vitiello G.; Luchini A.; D\u2019Errico G.; Santamaria R.; Capuozzo A.; Irace C.; Montesarchio D.; Paduano L.; Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex. J Mater Chem B Mater Biol Med 2015,3,3011-3023","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"16697","DOI":"10.1039\/c3dt52320a","volume":"42","author":"Montesarchio D.","year":"2013","unstructured":"Montesarchio D.; Mangiapia G.; Vitiello G.; Musumeci D.; Irace C.; Santamaria R.; D\u2019Errico G.; Paduano L.; A new design for nucleolipid-based Ru(III) complexes as anticancer agents. Dalton Trans 2013,42(48),16697-16708","journal-title":"Dalton Trans"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"45236","DOI":"10.1038\/srep45236","volume":"7","author":"Irace C.","year":"2017","unstructured":"Irace C.; Misso G.; Capuozzo1, A.; Piccolo1, M.; Riccardi, C.; Luchini, A.; Caraglia, M.; Paduano, L.; Montesarchio, D.; Santamaria, R. Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. Sci Rep 2017,7,45236","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1039\/C7CS00680B","volume":"46","author":"Poynton F.E.","year":"2017","unstructured":"Poynton F.E.; Bright S.A.; Blasco S.; Williams D.C.; Kelly J.M.; Gunnlaugsson T.; The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications. Chem Soc Rev 2017,46(24),7706-7756","journal-title":"Chem Soc Rev"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/cbic.200900769","volume":"11","author":"Gottschaldt M.","year":"2010","unstructured":"Gottschaldt M.; Schubert U.S.; Rau S.; Yano S.; Vos J.G.; Kroll T.; Clement J.; Hilger I.; Sugar-selective enrichment of a D-glucose-substituted ruthenium bipyridyl complex inside HepG2 cancer cells. ChemBioChem 2010,11(5),649-652","journal-title":"ChemBioChem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"18484","DOI":"10.1002\/chem.201603066","volume":"22","author":"Lameijer L.N.","year":"2016","unstructured":"Lameijer L.N.; Hopkins S.L.; Brev\u00e9 T.G.; Askes S.H.C.; Bonnet S.D.; Versus l-glucose conjugation: mitochondrial targeting of a light-activated dual-mode-of-action ruthenium-based anticancer prodrug. Chemistry 2016,22(51),18484-18491","journal-title":"Chemistry"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.acthis.2010.02.004","volume":"113","author":"Ghazarian H.","year":"2011","unstructured":"Ghazarian H.; Idoni B.; Oppenheimer S.B.; A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 2011,113(3),236-247","journal-title":"Acta Histochem"},{"key":"ref=53","first-page":"41","volume":"15","author":"Santos A.F.S.","year":"2014","unstructured":"Santos A.F.S.; da Silva M.D.C.; Napole\u00e3o T.H.; Paiva P.M.G.; Correia M.T.S.; Coelho L.C.B.B.; Lectins: function, structure, biological properties and potential applications. Curr Top Pept Protein Res 2014,15,41-62","journal-title":"Curr Top Pept Protein Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"53R","DOI":"10.1093\/glycob\/cwh122","volume":"14","author":"Sharon N.","year":"2004","unstructured":"Sharon N.; Lis H.; History of lectins: From hemagglutinins to biological recognition molecules. Glycobiology 2004,14(11),53R-62R","journal-title":"Glycobiology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1016\/S0040-4039(01)00424-5","volume":"42","author":"Hasegawa T.","year":"2001","unstructured":"Hasegawa T.; Yonemura T.; Matsuura K.; Kobayashi K.; Tris-bipyridine ruthenium complex-based glyco-clusters: Amplified luminescence and enhanced lectin affinities. Tetrahedron Lett 2001,42,3989-3992","journal-title":"Tetrahedron Lett"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1021\/bc900101u","volume":"20","author":"Tomoko Okada T.","year":"2009","unstructured":"Tomoko Okada T.; Makino T.; Minoura N.; Fluorescence emission and polarization for analyzing binding of ruthenium metalloglycocluster to lectin and tetanus toxin c-fragment. Bioconjug Chem 2009,20,1296-1298","journal-title":"Bioconjug Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1039\/B210739B","author":"Kojima S.","year":"2003","unstructured":"Kojima S.; Hasegawa T.; Yonemura T.; Sasaki K.; Yamamoto K.; Makimura Y.; Takahashi T.; Suzuki T.; Suzuki Y.; Kobayashi K.; Ruthenium complexes carrying a disialo complex-type oligosaccharide: enzymatic synthesis and its application to a luminescent probe to detect influenza viruses. Chem Commun (Camb) 2003(11),1250-1251","journal-title":"Chem Commun (Camb)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/cr400362r","volume":"114","author":"Mignani S.","year":"2014","unstructured":"Mignani S.; El Kazzouli S.; Bousmina M.M.; Majoral J-P.; Dendrimer space exploration: an assessment of dendrimers\/dendritic scaffolding as inhibitors of protein-protein interactions, a potential new area of pharmaceutical development. Chem Rev 2014,114(2),1327-1342","journal-title":"Chem Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jinorgbio.2018.01.001","volume":"181","author":"Michlewska S.","year":"2018","unstructured":"Michlewska S.; Ionov M.; Maroto-D\u00edaz M.; Szwed A.; Ihnatsyeu-Kachan A.; Loznikova S.; Shcharbin D.; Maly M.; Ramirez R.G.; de la Mata F.J.; Bryszewska M.; Ruthenium dendrimers as carriers for anticancer siRNA. J Inorg Biochem 2018,181,18-27","journal-title":"J Inorg Biochem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1039\/B814146K","author":"Kikkeri R.","year":"2009","unstructured":"Kikkeri R.; Garc\u00eda-Rubio I.; Seeberger P.H.; Ru(II)-carbohydrate dendrimers as photoinduced electron transfer lectin biosensors. Chem Commun (Camb) 2009(2),235-237","journal-title":"Chem Commun (Camb)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1039\/b925113h","volume":"46","author":"Kikkeri R.","year":"2010","unstructured":"Kikkeri R.; Liu X.; Adibekian A.; Tsai Y.H.; Seeberger P.H.; Facile synthesis of size dependent Ru(II)-carbohydrate dendrimers via click chemistry. Chem Commun (Camb) 2010,46(13),2197-2199","journal-title":"Chem Commun (Camb)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1021\/la9038792","volume":"26","author":"Kikkeri R.","year":"2010","unstructured":"Kikkeri R.; Kamena F.; Gupta T.; Hossain L.H.; Boonyarattanakalin S.; Gorodyska G.; Beurer E.; Coullerez G.; Textor M.; Peter H.; Seeberger, P. H. Ru(II) glycodendrimers as probes to study lectin-carbohydrate interactions and electrochemically measure monosaccharide and oligosaccharide concentrations. Langmuir 2010,26(3),1520-1523","journal-title":"Langmuir"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2533\/chimia.2007.698","volume":"61","author":"Dyson P.J.","year":"2007","unstructured":"Dyson P.J.; Systematic design of a targeted organometallic antitumour drug in pre-clinical development. Chimia (Aarau) 2007,61,698-703","journal-title":"Chimia (Aarau)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2533\/chimia.2007.704","volume":"61","author":"Dougan S.J.","year":"2007","unstructured":"Dougan S.J.; Sadler P.J.; The design of organometallic ruthenium arene anticancer agents. Chimia (Aarau) 2007,61,704-715","journal-title":"Chimia (Aarau)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1021\/jm2002074","volume":"54","author":"Nowak-Sliwinska P.","year":"2011","unstructured":"Nowak-Sliwinska P.; van Beijnum J.R.; Casini A.; Nazarov A.A.; Wagni\u00e8res G.; van den Bergh H.; Dyson P.J.; Griffioen A.W.; Organometallic ruthenium(II) arene compounds with antiangiogenic activity. J Med Chem 2011,54(11),3895-3902","journal-title":"J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1021\/jm010051m","volume":"44","author":"Morris R.E.","year":"2001","unstructured":"Morris R.E.; Aird R.E.; Murdoch, Pdel.S.; Chen, H.; Cummings, J.; Hughes, N.D.; Parsons, S.; Parkin, A.; Boyd, G.; Jodrell, D.I.; Sadler, P.J. Inhibition of cancer cell growth by ruthenium(II) arene complexes. J Med Chem 2001,44(22),3616-3621","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1021\/jm050015d","volume":"48","author":"Scolaro C.","year":"2005","unstructured":"Scolaro C.; Bergamo A.; Brescacin L.; Delfino R.; Cocchietto M.; Laurenczy G.; Geldbach T.J.; Sava G.; Dyson P.J.; \n                        In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes. J Med Chem 2005,48(12),4161-4171","journal-title":"J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1039\/B916860P","volume":"39","author":"S\u00fcss-Fink G.","year":"2010","unstructured":"S\u00fcss-Fink G.; Arene ruthenium complexes as anticancer agents. Dalton Trans 2010,39(7),1673-1688","journal-title":"Dalton Trans"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/589686","volume":"2014","author":"Therrien B.","year":"2014","unstructured":"Therrien B.; Furrer J.; The biological side of water-soluble arene ruthenium assemblies. Adv Chem 2014,2014,1-20","journal-title":"Adv Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"9046","DOI":"10.1002\/chem.200801032","volume":"14","author":"Berger I.","year":"2008","unstructured":"Berger I.; Hanif M.; Alexey A.; Nazarov, A. A.; Hartinger, C. G.; John, R. O.; Kuznetsov, M. L.; Groessl, M.; Schmitt, F.; Zava, O.; Biba, F.; Arion, V. B.; Galanski, M.; Jakupec, M. A.; Juillerat-Jeanneret, L.; Paul J. Dyson, P. J.; Keppler, B. K. Chemistry 2008,14,9046-9057","journal-title":"Chemistry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jinorgbio.2010.10.004","volume":"105","author":"Muhammad Hanif M.","year":"2011","unstructured":"Muhammad Hanif M.; Meier S.M.; Kandioller W.; Bytzek A.; Hejl; M.; Hartinger, C. G.; Nazarov, A. A.; Arion, V. B.; Jakupec, M. A.; Dyson, P. J.; Keppler, B. K. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands. J Inorg Biochem 2011,105,224-231","journal-title":"J Inorg Biochem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fchem.2013.00027","volume":"1","author":"Hanif M.","unstructured":"Hanif M.; Meier S.M.; Nazarov A.A.; Risse J.; Legin A.; Casini A.; Jakupec M.A.; Keppler B.K.; Hartinger C.G.; Influence of the \u03c0-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes. Front Chem ,1,27","journal-title":"Front Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1021\/ic202530j","volume":"51","author":"Nazarov A.A.","year":"2012","unstructured":"Nazarov A.A.; Risse J.; Ang W.H.; Schmitt F.; Zava O.; Ruggi A.; Groessl M.; Scopelitti R.; Juillerat-Jeanneret L.; Hartinger C.G.; Paul J.; Dyson, P. J. Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds. Inorg Chem 2012,51,3633-3639","journal-title":"Inorg Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/sj.bjc.6600290","volume":"86","author":"Aird R.E.","year":"2002","unstructured":"Aird R.E.; Cummings J.; Ritchie A.A.; Muir M.; Morris R.E.; Chen H.; Sadler P.J.; Jodrell D.I.; In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer 2002,86(10),1652-1657","journal-title":"Br J Cancer"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1021\/mp300723b","volume":"10","author":"Grau-Campistany A.","year":"2013","unstructured":"Grau-Campistany A.; Massaguer A.; Carrion-Salip D.; Barrag\u00e1n F.; Artigas G.; L\u00f3pez-Sen\u00edn P.; Moreno V.; March\u00e1n V.; Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells. Mol Pharm 2013,10(5),1964-1976","journal-title":"Mol Pharm"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/PMC.S2381","volume":"3","author":"Chittapragada M.","year":"2009","unstructured":"Chittapragada M.; Roberts S.; Ham Y.W.; Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics. Perspect Medicin Chem 2009,3,21-37","journal-title":"Perspect Medicin Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/cbic.200900779","volume":"11","author":"Houghton J.L.","year":"2010","unstructured":"Houghton J.L.; Green K.D.; Chen W.; Garneau-Tsodikova S.; The future of aminoglycosides: the end or renaissance? ChemBioChem 2010,11(7),880-902","journal-title":"ChemBioChem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jinorgbio.2008.11.016","volume":"103","author":"Garcia M.H.","year":"2009","unstructured":"Garcia M.H.; Morais T.S.; Florindo P.; Piedade M.F.M.; Moreno V.; Ciudad C.; Noe V.; Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands. J Inorg Biochem 2009,103,354-361","journal-title":"J Inorg Biochem"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/936834","author":"Moreno V.","year":"2010","unstructured":"Moreno V.; Lorenzo J.; Aviles F.X.; Garcia M.H.; Ribeiro J.P.; Morais T.S.; Florindo P.; Robalo M.P.; Studies of the antiproliferative activity of ruthenium (ii) cyclopentadienyl-derived complexes with nitrogen coordinated ligands. Bioinorg. Chem. Appl. Article\nID 936834 1-11.2010"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jinorgbio.2010.10.009","volume":"105","author":"Moreno V.","year":"2011","unstructured":"Moreno V.; Font-Bardia M.; Calvet T.; Lorenzo J.; Avil\u00e9s F.X.; Garcia M.H.; Morais T.S.; Valente A.; Robalo M.P.; DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands. J Inorg Biochem 2011,105(2),241-249","journal-title":"J Inorg Biochem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jinorgbio.2012.06.016","volume":"117","author":"Tomaz A.I.","year":"2012","unstructured":"Tomaz A.I.; Jakusch T.; Morais T.S.; Marques F.; de Almeida R.F.; Mendes F.; Enyedy \u00c9.A.; Santos I.; Pessoa J.C.; Kiss T.; Garcia M.H.; [RuII(\u03b7-CH)(bipy)(PPh)], a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin. J Inorg Biochem 2012,117,261-269","journal-title":"J Inorg Biochem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jinorgbio.2013.01.011","volume":"122","author":"Morais T.S.","year":"2013","unstructured":"Morais T.S.; Santos F.; C\u00f4rte-Real L.; Marques F.; Robalo M.P.; Madeira P.J.A.; Garcia M.H.; Biological activity and cellular uptake of [Ru(\u03b75-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex. J Inorg Biochem 2013,122,8-17","journal-title":"J Inorg Biochem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.09.013","volume":"130","author":"Morais T.S.","year":"2014","unstructured":"Morais T.S.; Santos F.C.; Jorge T.F.; C\u00f4rte-Real L.; Madeira P.J.; Marques F.; Robalo M.P.; Matos A.; Santos I.; Garcia M.H.; New water-soluble ruthenium(II) cytotoxic complex: biological activity and cellular distribution. J Inorg Biochem 2014,130,1-14","journal-title":"J Inorg Biochem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00775-014-1120-y","volume":"19","author":"C\u00f4rte-Real L.","year":"2014","unstructured":"C\u00f4rte-Real L.; Mendes F.; Coimbra J.; Morais T.S.; Tomaz A.I.; Valente A.; Garcia M.H.; Santos I.; Bicho M.; Marques F.; Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes. J Biol Inorg Chem 2014,19(6),853-867","journal-title":"J Biol Inorg Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jinorgbio.2015.06.015","volume":"150","author":"C\u00f4rte-Real L.","year":"2015","unstructured":"C\u00f4rte-Real L.; Robalo M.P.; Marques F.; Nogueira G.; Avecilla F.; Silva T.J.L.; Santos F.C.; Tomaz A.I.; Garcia M.I.; Valente A.; The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: ranging from non-cytotoxic to highly cytotoxic compounds. J Biol Inorg Chem 2015,150,148-159","journal-title":"J Biol Inorg Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jinorgbio.2013.07.002","volume":"127","author":"Valente A.","year":"2013","unstructured":"Valente A.; Garcia M.H.; Marques F.; Miao Y.; Rousseau C.; Zinck P.; First polymer \u201cruthenium-cyclopentadienyl\u201d complex as potential anticancer agent. J Inorg Biochem 2013,127,79-81","journal-title":"J Inorg Biochem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jorganchem.2013.09.004","volume":"760","author":"Florindo P.","year":"2014","unstructured":"Florindo P.; Marques I.J.; Nunes C.D.; Fernandes A.C.; Synthesis, characterization and cytotoxicity of cyclopentadienyl ruthenium(II) complexes containing carbohydrate-derived ligands. J Organomet Chem 2014,760,240-247","journal-title":"J Organomet Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1002\/ejic.200900766","volume":"31","author":"Walker J.M.","year":"2009","unstructured":"Walker J.M.; McEwan A.; Pycko R.; Tassotto M.L.; Gottardo C.; Th\u2019ng J.; Wang R.; Spivak G.J.; [Tris(pyrazolyl)methane]ruthenium complexes capable of inhibiting cancer cell growth. Eur J Inorg Chem 2009,31,4629-4633","journal-title":"Eur J Inorg Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1021\/acs.jmedchem.5b00403","volume":"58","author":"Florindo P.R.","year":"2015","unstructured":"Florindo P.R.; Pereira D.M.; Borralho P.M.; Rodrigues C.M.P.; Piedade M.F.M.; Fernandes A.C.; Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents. J Med Chem 2015,58(10),4339-4347","journal-title":"J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1039\/C6DT01571A","volume":"45","author":"Florindo P.R.","year":"2016","unstructured":"Florindo P.R.; Pereira D.M.; Borralho P.M.; Costa P.J.; Piedade M.F.M.; Rodrigues C.M.P.; Fernandes A.C.; New [(\u03b7(5)-C5H5)Ru(N-N)(PPh3)][PF6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes. Dalton Trans 2016,45(30),11926-11930","journal-title":"Dalton Trans"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1039\/c2cs15317c","volume":"41","author":"Rom\u00e3o C.C.","year":"2012","unstructured":"Rom\u00e3o C.C.; Walter A.; Bl\u00e4ttler W.A.; Seixas J.D.; Bernardes G.J.L.; Developing drug molecules for therapy with carbon monoxide. Chem Soc Rev 2012,41,3571-3583","journal-title":"Chem Soc Rev"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"18045","DOI":"10.1039\/C6DT03515A","volume":"45","author":"Kautz A.C.","year":"2016","unstructured":"Kautz A.C.; Kunz P.C.; Janiak C.; CO-releasing molecule (CORM) conjugate systems. Dalton Trans 2016,45(45),18045-18063","journal-title":"Dalton Trans"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/AAC.05571-11","volume":"56","author":"Pena A.C.","year":"2012","unstructured":"Pena A.C.; Penacho N.; Mancio-Silva L.; Neres R.; Seixas J.D.; Fernandes A.C.; Rom\u00e3o C.C.; Mota M.M.; Bernardes G.J.L.; Pamplona A.; A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother 2012,56(3),1281-1290","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/srep01485","volume":"3","author":"Nazarov A.A.","year":"2013","unstructured":"Nazarov A.A.; Baqui\u00e9 M.; Nowak-Sliwinska P.; Zava1, O.; van Beijnum, J. R.; Groessl1, M.; Chisholm, D. M.; Ahmadi, Z.; McIndoe, J. S.; Griffioen, A. W.; van den Bergh, H.; Dyson, P. J. Sci Rep 2013,3,1485","journal-title":"Sci Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jinorgbio.2015.06.018","volume":"153","author":"Fern\u00e1ndez M.","year":"2015","unstructured":"Fern\u00e1ndez M.; Arce E.R.; Sarniguet C.; Morais T.S.; Tomaz A.I.; Azar C.O.; Figueroa R.; Maya J.D.; Medeiros A.; Comini M.; Garcia M.H.; Otero L.; Gambino D.; Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasite. J Biol Inorg Chem 2015,153,306-314","journal-title":"J Biol Inorg Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1080\/00958972.2015.1062480","volume":"68","author":"Arce E.R.","year":"2015","unstructured":"Arce E.R.; Sarniguet C.; Morais T.S.; Vieites M.; Tomaz A.I.; Medeiros A.; Comini M.A.; Varela J.; Cerecetto H.; Gonz\u00e1lez M.; Marques F.; Garcia. M. H.; Otero, L.; Gambino, D. A new ruthenium cyclopentadienyl azole compound with activity on tumor cell lines and trypanosomatid parasites. J Coord Chem 2015,68,2923-2937","journal-title":"J Coord Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/jm950729w","volume":"39","author":"Sanche-Delgado R.A.","year":"1996","unstructured":"Sanche-Delgado R.A.; Navarro M.; Perez H.; Urbina. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. J A J Med Chem 1996,39(5),1095-1099","journal-title":"J A J Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0192-0561(95)00079-8","volume":"17","author":"Dwyer D.S.","year":"1995","unstructured":"Dwyer D.S.; Gordon K.; Jones B.; Ruthenium Red potently inhibits immune responses both in vitro and in vivo. Int J Immunopharmacol 1995,17(11),931-940","journal-title":"Int J Immunopharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1021\/ic960355c","volume":"35","author":"Clarke M.J.","year":"1996","unstructured":"Clarke M.J.; Bailey V.M.; Doan P.E.; Hiller C.D.; LaChance-Galang K.J.; Daghlian H.; Mandal S.; Bastos C.M.; Lang D.; 1H NMR, EPR, UV-Vis, and electrochemical studies of imidazole complexes of Ru(III). crystal structures of cis-[(Im)(2)(NH(3))(4)Ru(III)]Br(3) and [(1MeIm)(6)Ru(II)]Cl(2).2H(2)O. Inorg Chem 1996,35(17),4896-4903","journal-title":"Inorg Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-328X(02)01926-5","volume":"668","author":"Allardyce C.S.","year":"2003","unstructured":"Allardyce C.S.; Dyson P.J.; Ellis D.J.; Salter P.A.; Scopelliti R.; Synthesis and characterisation of some water soluble ruthenium(II)-arene complexes and an investigation of their antibiotic and antiviral properties. J Organomet Chem 2003,668,35-42","journal-title":"J Organomet Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1039\/C4CS00343H","volume":"44","author":"Li F.","year":"2015","unstructured":"Li F.; Collins J.G.; Keene F.R.; Ruthenium complexes as antimicrobial agents. Chem Soc Rev 2015,44(8),2529-2542","journal-title":"Chem Soc Rev"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/cr000074t","volume":"102","author":"Hayton T.W.","year":"2002","unstructured":"Hayton T.W.; Legzdins P.; Sharp W.B.; Coordination and organometallic chemistry of metal-NO complexes. Chem Rev 2002,102(4),935-992","journal-title":"Chem Rev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:26:37Z","timestamp":1579692397000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169321\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":102,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019,12,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190124124350","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}